Scott Saywell

Scott Saywell joined Coherus in 2023 as Executive Vice President of Corporate Development. Scott has over twenty-five years of experience in the biotech industry in a variety of functional roles, most recently as Chief Business Officer at Herophilus, Inc.

Prior to that, Scott was Vice President of Corporate Development and Strategy at Theravance Biopharma, Inc. Across several companies, Scott has completed out-licensing and divestiture transactions with a combined potential value of more than $2B. Prior to his business development roles, Scott led the commercialization planning and pre-launch activities for a first-in-class personalized cancer vaccine and contributed to establishing one of the world’s first high-throughput DNA sequencing operations.

Scott has a BS from UCLA and an MBA from the Kellogg School of Management, Northwestern University.